Medtronic is the global leading medical technology company. Headquarter is in Minneapolis, Minnesota in the United States.
Medtronic was founded in 1949 by Earl Bakken and Palmer J. Hermundslie. Medtronic built the first battery-powered cardiac pacemaker in 1957 and the first implantable cardiac pacemaker in 1960，that paved the way for Medtronic’s dominance in globe pace-making technology.
美敦力公司目前是全球领先的医疗科技公司，总部位于美国明尼苏达州的明尼阿波利斯市。
美敦力成立于1949年，由Earl E.Bakken及Palmer J.Hermundslie建立。
美敦力于1957年制造出第一台便携式体外心脏起搏器，并于1960年制造出第一台可靠的可植入式心脏起搏系统。由此奠定了美敦力全球起搏技术领导者的地位。
Regarding Kanghui
Changzhou Kanghui Medical Innovation Co., Ltd. (“Kanghui”) is a leading developer of orthopedic products in China. Orthopedic implant materials are the main products, widely used in the field of human traumatic restoration and spinal deformity correction. In November 2012, Medtronic, Inc., the global leading medical technology company, announced that it has completed its acquisition of Kanghui, making it the first Medtronic business unit headquartered outside the United States.
Located in Changzhou National Hi-Tech District, Kanghui has a rapidly increasing business performance. Kanghui has rapidly grown into an international medical device company with core competency, whose extensive sales and service network covers every province in China. It enters the international market as well and has sales in countries and regions like United States, Japan, EU, Latin America, Middle East, Southeast Asia, etc., providing the global patients with high-quality products and service.
Kanghui has a good prospect of accelerating its globalization by leveraging the scale and expertise of Medtronic after the acquisition. It will achieve the leapfrog development and promote the improvement and advancement of local medical device industry.
关于康辉
康辉医疗是我国骨科行业的领先企业、国家重点高新技术企业、全国外科植入物和矫形器械标准化技术委员会委员单位。公司主导产品为骨科植入材料，广泛应用于人体创伤修复、脊柱矫形等治疗领域。2012年11月，全球领先的医疗科技公司美国美敦力公司（Medtronic, Inc.）宣布完成了对康辉的并购，从此，康辉作为首个总部在美国之外的美敦力业务部门独立运营。
公司总部位于常州国家高新技术产业开发区，占地面积120亩，建筑面积超过8万平方米，注册资本4.7亿元，总投资达8亿元，资产总额超过10亿元，公司经营业绩每年快速增长，品牌建设硕果累累，公司被认定为国家高新技术企业，公司产品被认定为“江苏省名牌产品”；2009年至2012年连续四年被《福布斯》评选为 “中国最具潜力企业50强”。
在国际化职业经理人团队的带领下，康辉正快速成长为具有核心竞争力的国际化医疗器械企业。目前，公司的销售服务网络已覆盖了全国各省、市、自治区，并全面进军国际市场，产品已进入拉丁美洲、中东、非洲、印度、东南亚、欧洲地区，为全球患者提供高品质的产品和服务。加入美敦力后，借助美敦力的品牌、渠道和技术优势，有助于快速实现康辉医疗的全球化愿景。根据美敦力的全球战略规划，在未来十年内，作为美敦力旗下的重要业务分支，康辉将在美敦力全球版图中占据更为重要的位置，实现跨越式发展，不断推动本土医疗器械产业的发展和进步。
